These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2328750)

  • 1. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
    Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M; Safadi R; Zylber-Katz E; Granit L; Caraco Y
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of antipyrine metabolites in human plasma by solid-phase extraction and micellar liquid chromatography.
    Carretero I; Vadillo JM; Laserna JJ
    Analyst; 1995 Jun; 120(6):1729-32. PubMed ID: 7604956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
    Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
    Levy M; Flusser D; Zylber-Katz E; Granit L
    Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of two oral metamizole formulations. Influence of the acetylation phenotype.
    Bacracheva N; Drenska A; Gorantcheva J; Tyutyulkova N; Vlahov V
    Arzneimittelforschung; 1995 Mar; 45(3):282-5. PubMed ID: 7741785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis.
    Matzner Y; Drexler R; Levy M
    Eur J Clin Invest; 1984 Dec; 14(6):440-3. PubMed ID: 6441720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic assay for metamizol metabolites in rat plasma: application to pharmacokinetic studies.
    Domínguez-Ramírez AM; Calzadilla PC; Cortés-Arroyo AR; Hurtado Y de la Peña M; López JR; Gómez-Hernández M; López-Muñoz FJ
    J Pharm Biomed Anal; 2012 Dec; 71():173-8. PubMed ID: 22917546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.
    Heinemeyer G; Gramm HJ; Roots I; Dennhardt R; Simgen W
    Eur J Clin Pharmacol; 1993; 45(5):445-50. PubMed ID: 8112374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dipyrone in man; role of the administration route.
    Asmardi G; Jamali F
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):121-5. PubMed ID: 4043141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metamizol--acute overdose with suicidal intent].
    Wolhoff H; Altrogge G; Pola W; Sistovaris N
    Dtsch Med Wochenschr; 1983 Nov; 108(46):1761-4. PubMed ID: 6641523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets.
    Burmańczuk A; Kowalski C; Giorgi M; Owen H; Grabowski T
    J Vet Pharmacol Ther; 2016 Dec; 39(6):616-620. PubMed ID: 27199202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
    Hüller G; Haustein KO
    Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.